Safety Shot versus Its Rivals Financial Contrast
| SHOT Stock | 0.68 0.03 4.23% |
Slightly above 62% of Safety Shot's investor base is looking to short. The analysis of overall sentiment of trading Safety Shot stock suggests that many investors are alarmed at this time. Safety Shot's investing sentiment can be driven by a variety of factors including economic data, Safety Shot's earnings reports, geopolitical events, and overall market trends.
Safety |
Safety Shot is one of 266 publicly-traded companies in the Drug Manufacturers Specialty Generic industry, but how does it compare to its rivals We will compare Safety Shot to related companies based on the strength of its dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Profitability
Read at thelincolnianonline.com
 |
Safety Shot Fundamental Analysis
We analyze Safety Shot's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Safety Shot using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Safety Shot based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Safety Shot is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Safety Shot Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Safety Shot stock to make a market-neutral strategy. Peer analysis of Safety Shot could also be used in its relative valuation, which is a method of valuing Safety Shot by comparing valuation metrics with similar companies.
Peers
Safety Shot Related Equities
| SMMT | Summit Therapeutics | 8.36 | ||||
| SLS | Sellas Life | 7.14 | ||||
| APGE | Apogee Therapeutics, | 5.21 | ||||
| BH | Biglari Holdings | 3.08 | ||||
| SYRE | Spyre Therapeutics | 0.13 | ||||
| TARS | Tarsus Pharmaceuticals | 1.33 | ||||
| MNMD | Mind Medicine | 2.90 |
Additional Tools for Safety Stock Analysis
When running Safety Shot's price analysis, check to measure Safety Shot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safety Shot is operating at the current time. Most of Safety Shot's value examination focuses on studying past and present price action to predict the probability of Safety Shot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safety Shot's price. Additionally, you may evaluate how the addition of Safety Shot to your portfolios can decrease your overall portfolio volatility.